DEKK-TEC, INC.
Biotech · Private
DM-CHOC-PEN, a polychlorinated pyridine cholesteryl carbonate small-molecule anticancer therapeutic that crosses the blood-brain barrier and alkylates DNA in CNS tumors
- Grants
- $1.7M
- 8 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 8
- 2 granted · 6 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201520162017201820192020
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Phase I Clinical trial with 4-Demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in Children with Cancer Involving the CNS | $90,362 | |
| Federal grant | Department of Health and Human Services · Phase I · The DEKK-TEC I-Corp Team | $50,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Phase I Clinical trial with 4-Demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in Children with Cancer Involving the CNS | $90,362 | |
| Federal grant | Department of Health and Human Services · Phase I · A Phase I Clinical Trial: Binary Therapy with DM-CHOC-PEN and WBRT in Adults with Cancer Involving the CNS | $143,294 | |
| Federal grant | Department of Health and Human Services · Phase I · A Phase I Clinical Trial: Binary Therapy with DM-CHOC-PEN and WBRT in Adults with Cancer Involving the CNS | $143,294 | |
| Federal grant | Department of Health and Human Services · Phase II · 4-Demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN: A Phase II Clinical Trial in Adolescents/Young Adults (AYA)with CNS Malignancies | $240,368 | |
| Federal grant | Department of Health and Human Services · Phase II · 4-Demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN: A Phase II Clinical Trial in Adolescents/Young Adults (AYA)with CNS Malignancies | $519,480 | |
| Federal grant | Department of Health and Human Services · Phase II · 4-Demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN: A Phase II Clinical Trial in Adolescents/Young Adults (AYA)with CNS Malignancies | $451,382 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1240 | Bluerock Therapeutics | — | — |
| 1241 | Lattice Automation, Inc | — | — |
| 1242 | Antag Therapeutics | — | — |
| 1243 | DEKK-TEC, INC. | — | — |
| 1244 | QX Therapeutics, Inc. | — | — |
| 1245 | DIGITAL PROTEOMICS LLC | — | — |
| 1246 | New England Discovery Partners, LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Demethylpenclomedine Analogs And Their Use As Anti-cancer Agentsapplication
- Demethylpenclomedine Analogs And Their Use As Anti-cancer Agentsgranted
- Demethylpenclomedine Analogs And Their Use As Anti-cancer Agentsgranted
- Complexes Of 4-HYDROPEROXY Ifosfamide As Anti-tumor Agentsapplication
- Demethylpenclomedine Analogs And Their Use As Anti-cancer Agentsapplication
- Hydrazone Agents To Treat Cutaneous Lesionsapplication
- Conjugated Aromatic Compounds For Diagnosis And Therapyapplication
- Salts Of Isophosphoramide Mustard And Analogs Thereof As Anti-tumor Agentsapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.